Aktienanalyse zu Hyperliquid Strategies Inc (PURR)

$11.610

-1.104 (-9.51%)Zum Schluss

Loading chart…

High: 13.860
Open: 12.675
VWAP: 12.35
Vol: 38.01M
Mkt Cap: —
Low: 11.570
Amount: 469.36M
EV/EBITDA, TTM: 0.00

Hyperliquid Strategies Inc is a digital asset treasury company. The Company is focused on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. The Company’s subsidiary is Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action.

AI analysis of Hyperliquid Strategies Inc (PURR)

buy

Hyperliquid Strategies Inc (PURR) is a good buy right now due to its recent performance and strong financial indicators. The current price is $11.61, with a 1-year change of +821.43%, reflecting significant growth. Additionally, the RSI is at 66.679, indicating strong momentum. The main risk is the negative net income reported in Q1 2026, which was -1212921000.00 USD, but the company has shown recovery in subsequent quarters, with a net income of 421535000.00 USD in Q4 2026.

Bewertungskennzahlen

The current forward P/E ratio for Hyperliquid Strategies Inc (PURR) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E

Current P/E

0.00

Forward EV/EBITDA

5Y Average EV/EBITDA

Current EV/EBITDA

0.00

Forward P/S

Overvalued

5Y Average P/S

70.12

Current P/S

95.48

Überbewertet

87.50

Unterbewertet

52.75

Whales holding PURR

Duquesne Family Office LLC

+ HoldingPURR

+9.41%

3M Return

Event-Zeitleiste

2026-08-28 (ET)